30 Apr 2017 | 9:41 PM
 

Cipla Ltd. Share Price Live (BSE)
0

BSE Code: 500087 | NSE Symbol: CIPLA
556.80
-4.09
(-0.73 %)
28 Apr 2017 | 04:01 PM
Change company
  • Open (Rs)
    561.00
  • Prev. close (Rs.)
    560.90
  • High (Rs.)
    561.00
  • Low (Rs.)
    555.90
  • 52W H (Rs.)
    621.90
  • 52W L (Rs.)
    458.25
  • Volume (Rs.)
    92166
  • MCap (Rs in Cr.)
    43,899.95
560.65
-3.00
(-0.53 %)
  • Open (Rs)
    561.95
  • High (Rs)
    563.00
  • Low (Rs)
    559.00
  • Prev. close(Rs)
    563.65
  • Contracts Tra.
    10,33,000
  • Turnover (Cr.)
    58
  • Open Interest
    74,24,000
  • Open Int. chg
    1,66,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
18.74
Operating Margin (%)
18.28
Gross Profit Margin (%)
14.32
Net Profit Margin (%)
11.00
Total Debt/Equity
0.44
Dividend payout Ratio (Net Profit)
12.84
Earning Retention Ratio
87.67

News

13 Apr 2017 - 11:05:00-Drug firm Cipla said that it's subsidiary in South Africa has completed the acquisition of Anmar...
05 Apr 2017 - 09:44:00-Cipla Ltd a global pharmaceutical company has said that it has received final approval for its Abbre...
06 Mar 2017 - 00:15:00-Pharma major Cipla Ltd said that it has entered into an agreement to sell its animal health business...
19 Jan 2017 - 09:31:00-Leading pharma giant Cipla Ltd has said that Goldencross Pharma Private Limited wholly owned subsid...

Announcements

26-Apr-2017
Cipla - Allotment Of Equity Shares
26-Apr-2017
Cipla - Compliance Certificate For The Half Year Ended On 31St March 2017
25-Apr-2017
Cipla - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI Regulations For Half Year Ended 31St March 2017
25-Apr-2017
Cipla - Schedule Of Investor / Analyst Meeting
21-Apr-2017
Cipla - Shareholding for the Period Ended March 31 2017

Religare Research

28 Apr 2017 | 05:39 PM
The Nifty index gained 2% led by good quarterly earnings and positive global cues. Even though the o...
28 Apr 2017 | 05:35 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
28 Apr 2017 | 03:38 PM
Akshaya Tritiya is a very popular festival that the Hindus celebrate every year. It is considered as...
28 Apr 2017 | 01:31 PM
Nifty futures has rolled around 66% vs 68%, with respect to last month, and the open interest for th...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
28,50,036 194.42 31.72 0.19
28,50,036 194.42 134.07 0.19
28,50,036 194.42 139.82 0.20
28,50,036 194.42 50.88 0.20
23,43,750 159.88 1,034.27 0.81

Shareholding Pattern

       
Promotors37.48%
Mutual Funds/UTI9.45%
FI/Banks8.56%
Insurance8.56%
FII18.03%
Government0.00%
Others8.15%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,604.85(0.45)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,500.45(-2.25)
3317
 Piramal Enterprises Ltd.
2,490.00(0.74)
3356
 Alkem Laboratories Ltd.
1,964.90(2.55)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Cipla Ltd.-37.15-24.15-17.65
NIFTY(S&P CNX)203.25671.30666.05
BSE SENSEX508.882,068.841,976.89
BSE 500477.041,205.501,125.87

Corporate Details

Key Personal
M K Hamied
Vice Chairman
S Radhakrishnan
Whole Time Director
Samina Vaziralli
Executive Vice Chairman
Key Address
Registered Office
Cipla House Peninsula Business Park Ganpatrao Kadam Marg Lower Parel,Mumbai,Maharashtra

Tel:022-24826000 24826951, Fax:022-24826893

cosecretary@cipla.com
http://www.cipla.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Cipla Ltd. that will help you decide whether to buy, sell or hold Cipla Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Cipla Ltd.